文献速递泌尿生殖腹部MR

弥散加权成像用于慢性肾脏病分期:一项Meta分析

Diffusion-weighted imaging for staging chronic kidney disease: a meta-analysis.
PubMed 文献 · Br J Radiol · 2018-06-21

该Meta分析检索1999至2017年文献,纳入6项研究,比较健康组与不同分期慢性肾脏病(CKD)患者的表观弥散系数(ADC)值。CKD 1-2期ADC值低于健康组,CKD 3期与1-2期无显著差异,CKD 3期ADC值高于4-5期。结论认为DWI是CKD早期诊断和分期的准确无创技术,定量DWI可能有助于临床随访决策。

要点

  • CKD 1-2期ADC值较健康肾脏降低(WMD=-0.09,95%CI -0.12~-0.06,p<0.001)。
  • CKD 3期与1-2期ADC值无显著差异(WMD=-0.09,95%CI -0.18~0.01,p=0.08)。
  • CKD 3期ADC值高于4-5期(WMD=-0.21,95%CI -0.32~-0.11,p=0.01)。

核心结论

  • DWI是CKD早期诊断和分期的准确无创影像技术,定量DWI可能对CKD随访中的临床决策发挥作用。

研究设计与样本

  • Meta分析,检索PubMed、Web of Science、Cochrane和Embase 1999至2017年关于DWI在CKD中应用的相关文献,最终纳入6项研究,采用STATA v.12.0进行随机效应模型分析,效应量为合并加权均数差(WMD)及95%CI。

诊断标准与关键数值

  • 正常肾脏 vs CKD 1-2期:ADC值WMD=-0.09,95%CI(-0.12至-0.06),p<0.001,CKD 1-2期ADC值更低。
  • CKD 3期 vs CKD 1-2期:ADC值WMD=-0.09,95%CI(-0.18至0.01),p=0.08,无显著差异。
  • CKD 3期 vs CKD 4-5期:ADC值WMD=-0.21,95%CI(-0.32至-0.11),p=0.01,CKD 3期ADC值更高。

临床应用与阅片要点

  • 作者认为DWI可作为CKD分期的有价值工具。
  • 作者认为定量DWI可能对CKD随访中的临床决策发挥作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE:: To evaluate stages of chronic kidney disease (CKD) by apparent diffusion coefficient (ADC) obtained from diffusion weighted imaging (DWI) using a meta-analysis.

METHODS:: Literature databases were searched from PubMed, Web of Science, Cochrane and Embase to identify relevant articles about DWI in CKD between 1999 and 2017. ADC values were extracted from the healthy group and CKD patients with different stages. Meta-analysis was conducted using STATA v. 12.0. A random-effects model was performed to acquire the effect estimate, which was expressed as a pooled weighted mean difference (WMD) with 95% confidence interval (CI). We performed comparisons of ADC values between the following groups: (1) the ADC values of the normal kidneys vs earlier Stage 1-2 of CKD; (2) Stage 3 vs the Stage 1-2 of CKD; (3) the Stage 4-5 vs the Stage 3.

RESULTS:: Six studies were included in this meta-analysis. The CKD patients with earlier Stage 1-2 showed lower ADC values than the healthy subjects [WMD = -0.09, 95% CI(-0.12 to -0.06), p < 0.001]. However, no obvious difference in ADC values was found between the Stage 3 and Stage1-2 of CKD [WMD = -0.09, 95% CI (-0.18 to 0.01), p = 0.08]. The CKD Stage3 had higher ADC values than those of Stage4-5 [WMD = -0.21, 95% CI (-0.32 to -0.11), p = 0.01].

CONCLUSION:: DWI is an accurate and non-invasive imaging technique for early diagnosis and staging of CKD. Quantitative DWI may potentially play a role in making clinical decisions in the follow-up of CKD.

ADVANCES IN KNOWLEDGE: DWI can be a valuable tool for staging of CKD.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Liu H, Zhou Z, Li X, et al. Diffusion-weighted imaging for staging chronic kidney disease: a meta-analysis. Br J Radiol. 2018. PMID: 29888970. doi:10.1259/bjr.20170952

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。